Presentation is loading. Please wait.

Presentation is loading. Please wait.

Tetsuro Sakai, MD, Ren-Ke Li, MD, MSc, PhD, Richard D

Published byVivien Paré Modified over 5 years ago

Similar presentations

Presentation on theme: "Tetsuro Sakai, MD, Ren-Ke Li, MD, MSc, PhD, Richard D"— Presentation transcript:

1 The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat 
Tetsuro Sakai, MD, Ren-Ke Li, MD, MSc, PhD, Richard D. Weisel, MD, Donald A.G. Mickle, MD, Eung T.Joong Kim, MD, PhD, Zhi-Qian Jia, MD, MSc, Terrence M. Yau, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 121, Issue 5, Pages (May 2001) DOI: /mtc Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

2 Fig. 1 Adult heart cell-seeded patch in vitro. Hematoxylin and eosin staining of vertical sections after culturing for 3 weeks (A, 100×; B, 400×). The upper and lower surfaces were seeded sequentially. Full-thickness penetration of the cultured cells was found. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

3 Fig. 2 Cell growth in the gelatin patch. A, Fetal cardiomyocyte (FCM). B, Adult cardiomyocyte (ACM). Each point represents the mean ± the standard deviation. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

4 Fig. 3 Gross appearance of control patch at 4 weeks. A, The anterior view. B, Vertically sliced view. C, The endocardial surface view of the heart from a control rat. Note full thickness replacement of RVOT with the patch (arrows). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

5 Fig. 4 Thickness of the RVOT. Data are shown as the mean ± the standard deviation. The patches became significantly thinner with time as the scaffold dissolved in all groups. No difference in the thickness was found between the patch groups at 4 or 12 weeks. Compared with normal hearts, the fetal cardiomyocyte group was thicker (†P =.036) at 4 weeks, and the control group was thinner (‡P =.047) at 12 weeks. FCM, Fetal cardiomyocyte patch; ACM, adult cardiomyocyte patch. *P =.003. **P =.001. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

6 Fig. 5 Histologic studies of RVOT patch. A fetal cardiomyocyte patch 1 day after the implantation had tissue formation (A, 100×; B, 400×). At 4 weeks an inflammatory reaction was seen in all groups as the gelatin scaffold dissolved. The adult group is shown in C (100×) and D (400×). The control group is shown in E (100×) and F (400×). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

7 Fig. 6 Twelve weeks after the replacement (A, control group; B, adult group; C, fetal group; all magnified 100×). The gelatin structure of the patches had completely disappeared and the inflammatory reaction had resolved. Normal RVOT was shown for comparison (D, 100×). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

8 Fig. 7 BrdU staining (B and D ) with the corresponding hematoxylin and eosin staining (A and C ) of the seeded patches at 12 weeks after the replacement (A and B, fetal group; C and D, adult group; 400×). Some of the cells in the patched area stained positively (brown) for BrdU, indicating that they contained cultured cells seeded in the gelatin mesh. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

9 Fig. 8 Factor VIII staining (dark red) identified endothelial cells on the surface of the patch at 4 weeks after implantation in all groups. The fetal cardiomyocyte group is illustrated in A (400×) and the normal endocardial surface is shown in B (400×). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

Download ppt "Tetsuro Sakai, MD, Ren-Ke Li, MD, MSc, PhD, Richard D"

Similar presentations

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,
Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,

Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,
In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix–like topography  Osamu Ishii, MD, Michael Shin,

In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix–like topography  Osamu Ishii, MD, Michael Shin,
Cell transplantation to prevent heart failure: a comparison of cell types  Takeshiro Fujii, MD, Terrence M Yau, MD, MS, Richard D Weisel, MD, Nobuhisa.

Cell transplantation to prevent heart failure: a comparison of cell types  Takeshiro Fujii, MD, Terrence M Yau, MD, MS, Richard D Weisel, MD, Nobuhisa.
Uswa Shahzad, BHSc, Guangming Li, MD, Yaoguang Zhang, MD, Terrence M

Uswa Shahzad, BHSc, Guangming Li, MD, Yaoguang Zhang, MD, Terrence M
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery  Shu-Hong.

Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery  Shu-Hong.
Manuel J. Antunes, MD, PhD, DSc 

Manuel J. Antunes, MD, PhD, DSc 
Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery  Shu-Hong.

Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery  Shu-Hong.
Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation  Haitham J. Abunasra, FRCS,

Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation  Haitham J. Abunasra, FRCS,
Cardiomyocyte Transplantation Improves Heart Function

Cardiomyocyte Transplantation Improves Heart Function
Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury  Ren-Ke Li, MD, PhD, Donald A.G. Mickle,

Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury  Ren-Ke Li, MD, PhD, Donald A.G. Mickle,
Cell transplantation to prevent heart failure: a comparison of cell types  Takeshiro Fujii, MD, Terrence M Yau, MD, MS, Richard D Weisel, MD, Nobuhisa.

Cell transplantation to prevent heart failure: a comparison of cell types  Takeshiro Fujii, MD, Terrence M Yau, MD, MS, Richard D Weisel, MD, Nobuhisa.
Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction  Tamotsu Yasuda, MD, PhD, Richard D. Weisel,

Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction  Tamotsu Yasuda, MD, PhD, Richard D. Weisel,
Cell transplantation preserves cardiac function after infarction by infarct stabilization: Augmentation by stem cell factor  Shafie Fazel, MD, MSc, Liwen.

Cell transplantation preserves cardiac function after infarction by infarct stabilization: Augmentation by stem cell factor  Shafie Fazel, MD, MSc, Liwen.
Novel Tissue-Engineered Biodegradable Material for Reconstruction of Vascular Wall  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Satoshi Taketani, MD, Kei Torikai,

Novel Tissue-Engineered Biodegradable Material for Reconstruction of Vascular Wall  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Satoshi Taketani, MD, Kei Torikai,
Reconstruction of the right ventricular outflow tract with a bovine jugular vein graft fixed with a naturally occurring crosslinking agent (genipin) in.

Reconstruction of the right ventricular outflow tract with a bovine jugular vein graft fixed with a naturally occurring crosslinking agent (genipin) in.
Stem cell therapy in the aging hearts of Fisher 344 rats: Synergistic effects on myogenesis and angiogenesis  Jiang-Yong Min, MD, Yu Chen, MD, Sohail.

Stem cell therapy in the aging hearts of Fisher 344 rats: Synergistic effects on myogenesis and angiogenesis  Jiang-Yong Min, MD, Yu Chen, MD, Sohail.
Cellular coating of the left ventricular assist device textured polyurethane membrane reduces adhesion of Staphylococcus aureus  Tomohiro Asai, MD, Mei-Ho.

Cellular coating of the left ventricular assist device textured polyurethane membrane reduces adhesion of Staphylococcus aureus  Tomohiro Asai, MD, Mei-Ho.
Persistence of marrow stromal cells implanted into acutely infarcted myocardium: Observations in a xenotransplant model  Derek J. MacDonald, MD, Jun Luo,

Persistence of marrow stromal cells implanted into acutely infarcted myocardium: Observations in a xenotransplant model  Derek J. MacDonald, MD, Jun Luo,

Similar presentations

Ads by Google